Off Patent
December 2027

Cardene

nicardipine hydrochloride

Chiesi USA Inc

Injectable (injection); Injectable (intravenous) · NDA 019734

Last listed protection ends
December 26, 2027

The FDA lists 6 patents for Cardene, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,659,291
    Claims a use (U-1029)
  2. Patent 8,455,524
    Claims a use (U-1029)
  3. Patent 10,758,616
    Claims the drug product
  4. Patent 11,547,758
    Claims a use (U-1029)
  5. Patent 7,612,102
    Claims the drug product
  6. Patent 9,364,564
    Claims the drug product